Astex Pharmaceuticals Announces December 14th Analyst and Investor Day Agenda

Astex Pharmaceuticals, Inc. logo

DUBLIN, Calif., Dec. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the agenda for its Analyst and Investor Day webcast, to take place from 10 am to 12:15 pm GMT on Friday, December 14th in London, UK.

Investors and interested parties may access the webcast in the Investor Events section of the Company's website, www.astx.com. A webcast replay will be available for 90 days following the live event.

10:00 (5 min.) Welcome and Introductions Timothy L. Enns
SVP, Corporate Communications and Marketing
10:05 (10 min.) Corporate Overview James S.J. Manuso, PhD, MBA
Chairman and Chief Executive Officer
10:15 (20 min.) Clinical Update Mohammad Azab, MD, M Sc, MBA
Chief Medical Officer
10:35 (25 min.) AT13387 & Prostate Cancer Johann de Bono, MD, PhD
Royal Marsden Hospital
Institute of Cancer Research (ICR)
11:00 (25 min.) SGI-110 & Ovarian Cancer Robert Brown, PhD
Imperial College London
Institute of Cancer Research (ICR)
11:25 (20 min.) Research & Discovery Harren Jhoti, PhD
President and Director
11:45 (15 min.) Partnering & Corporate Development Martin Buckland, DPhil, MBA
Chief Business Officer
12:00 (10 min.) Financial Overview Michael Molkentin, CPA
Chief Financial Officer and Corporate Secretary
12:10 (5 min.) Closing Remarks James S.J. Manuso, PhD, MBA
Chairman and Chief Executive Officer

The times listed above are approximate and are subject to change.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.

The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273

CONTACT: Timothy L. Enns Astex Pharmaceuticals, Inc. Senior Vice President Corporate Communications & Marketing Tel: +1 (925) 560-2810 E-mail: tim.enns@astx.com Susanna Chau Astex Pharmaceuticals, Inc. Manager Investor Relations Tel: +1 (925) 560-2845 E-mail: susanna.chau@astx.com Alan Roemer The Trout Group Managing Director Tel: +1 (646) 378-2945 E-mail: aroemer@troutgroup.com Kari Watson MacDougall Biomedical Communications Senior Vice President Tel: +1 (781) 235-3060 E-mail: kwatson@macbiocom.com

Source:Astex Pharmaceuticals, Inc.

More From Press Releases